Gross Profit (Annual)

Gross Profit: Revenues from operations less the associated costs.

Core Laboratories Inc. (CLB) had Gross Profit of $108.93M for the most recently reported fiscal year, ending 2025-12-31.

Quarterly Annual

Figures for fiscal year ending 2025-12-31

Income Statement Financials
Revenue	$526.52M
Net Income	$29.67M
Cost of Goods Sold	$417.59M
Gross Profit	$108.93M
Operating Expenses	$470.05M
Operating Income	$56.47M
Non-Operating Income/Expense	$-10.57M
Pre-Tax Income	$45.90M
Normalized Pre-Tax Income	$45.90M
Income after Taxes	$30.39M
Income from Continuous Operations	$30.39M
Consolidated Net Income/Loss	$30.39M
Normalized Income after Taxes	$30.39M
EBIT	$56.47M
EBITDA	$71.12M
Weighted-Average Shares Outstanding (Basic)	46.43M
Weighted-Average Shares Outstanding (Diluted)	47.03M
Earnings per Share (EPS) (Basic)	$0.64
Earnings per Share (EPS) (Diluted)	$0.63
Balance Sheet Financials
Current Assets	$214.66M
Property, Plant, and Equipment	$99.45M
Long-Term Assets	$369.35M
Total Assets	$584.01M
Current Liabilities	$106.02M
Long-Term Debt	$110.25M
Long-Term Liabilities	$205.79M
Total Liabilities	$311.80M
Common Equity	$272.21M
Tangible Shareholders Equity	$159.30M
Shareholders Equity	$272.21M
Common Shares Outstanding	46.09M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$37.03M
Cash Flow from Investing Activities	$-2.23M
Cash Flow from Financial Activities	$-31.25M
Beginning Cash	$19.16M
End Cash	$22.70M
Increase/Decrease in Cash	$3.54M
Stock-Based Compensation	$7.14M
Common Stock Dividends Paid	$-1.87M
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	2.02
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.29
Debt to Equity Ratio	0.41
Gross Margin	20.69%
Operating Margin	10.72%
EBIT Margin	10.72%
EBITDA Margin	13.51%
Pre-Tax Profit Margin	8.72%
Profit Margin	5.63%
Free Cash Flow	$25.46M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.90
Inventory Turnover	7.66
Receiveable Turnover	4.36
Days Sales in Receivables	83.74
Return on Equity	11.16%
Return on Tangible Equity	19.08%
Return on Assets	5.20%
Return on Investments	7.95%
Book Value Per Share	$5.91
Free Cash Flow per Share	$0.54
Operating Cash Flow per Share	$0.79

Data from Zacks Investment Research, Inc.